Chronic Pain

In response to the insightful cover story, “‘A potent medicine’: In matters of pain and trust, empathy may make all the difference,” published in the Healio Rheumatology January 2025 issue, I would like to highlight the key data on empathy.

Patients with kidney disease may be using cannabis recreationally or to treat symptoms without the knowledge of their health care team, according to results of a small survey of patients from a hemodialysis clinic in Canada.

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy, according to results of a systematic review and meta-analysis published in Regional Anesthesia & Pain Medicine.

Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from allergies to these medications.

American Society of Hematology has issued new sickle cell disease research priorities, highlighting seven key focus areas for maximum impact and benefit to patients.

SAN DIEGO — Pain coping skills training may be beneficial for pain interference and related outcomes for patients on hemodialysis, according to data presented at ASN Kidney Week.

SAN DIEGO — Kidney transplant recipients who experience more bodily pain have less involvement and ability to participate in social activities than kidney transplant patients who report less pain, according to data at ASN Kidney Week.

Patients with chronic pain showed greater support for several policies expanding access to cannabis compared with physicians, a research letter in JAMA Network Open showed.

SAN DIEGO — Improving depressive symptoms can reduce patients’ chronic pain, according to a presenter at the 2024 Congress of Clinical Rheumatology West.

Long-term use of skeletal muscle relaxants may be beneficial only for the treatment of a narrow subset of chronic pain conditions, according to the findings of a systematic review published in JAMA Network Open.